Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro

Cornea

Volumn 26, Issue 6, 2007, Pages 720-725

  Kim, Su Young ^a   Lim, Jung A ^a   Choi, Jun Sub ^a   Choi, Eung Chil ^b   Joo, Choun Ki ^a,c  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Fluoroquinolone; Levofloxacin; Moxifloxacin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBIOTIC AGENT; CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; CORNEA EPITHELIUM; EYE TOXICITY; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTERIOLOGICAL TECHNIQUES; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; EPITHELIUM, CORNEAL; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PSEUDOMONAS AERUGINOSA; QUINOLINES; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

EID: 34447519029     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3180515251     Document Type: Article

References (13)

1. Hooper DC, Wolfson JS. Mode of action of the quinolone antimicrobial agents. Rev Infect Dis. 1988;10(Suppl 1):S14-S21.
2. Mather R, Karenchak LM, Romanowski EG, et al. Fourth-generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463-466.
3. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol. 2003;136:500-505.
4. Yamamoto N, Yamamoto N, Petrol MW, et al. Internalization of Pseudomonas aeruginosa is mediated by lipid rafts in contact lenswearing rabbit and cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:1348-1355.
5. Thibodeaux BA, Dajcs JJ, Caballero AR, et al. Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Curr Eye Res. 2004;28:337-342.
6. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61:377-392.
7. Ince D, Hooper DC. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45:2755-2764.
8. Tanaka M, Wang T, Onodera Y, et al. Mechanism of quinolone resistance in Staphylococcus aureus. J Infect Chemother. 2000;6:131-139.
9. Wang M, Tran JH, Jacoby GA, et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003;47:2242-2248.
10. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat. 1999;2:38-55.
11. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10:S122-S129.
12. Kovoor TA, Kim AS, McCulley JP, et al. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Contact Lens. 2004;30:90-94.
13. De Saint Jean M, Brignole F, Bringuier AF, et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999;40:619-630.